Calls for Proposals FY 2023 Advanced Research and Development Programs for Medical Innovation (AMED-CREST, PRIME)
Change log
30th May, 2023
"Interview schedule" has been corrected. [R&D area (AMED-CREST): Bridging the fundamental mechanism of aging and the effective treatment of age-related disease associated with impaired functional system]
18th May, 2023
“Public invitation briefing” has been updated. [R&D area: Elucidation of mechanisms for stress responses to disease development]
12th May, 2023
"Public offering content", "Interview Schedule", "Public invitation briefing", "Proposal Documents", and "Application Guidelines" have been updated.
Outline
Status of Grants/Funding Opportunities | Grants/Funding Opportunities |
---|---|
R&D Phase | Basic Study |
Key Fields | Project for Seeds Development and Research Base, Cancer, Life style disease (Diabetes, Hypertension etc.), Neurological and Psychiatric disorders, Aging and Dementia, Intractable disease/Rare disease, Child health and development, Infectious disease, other |
Submission Deadline | 05/30/23 Tue Noon (Japan standard time) No exceptions for delay |
Contact |
|
Public offering content
Elucidation of mechanisms for stress responses to disease development
Program Supervisor (PS): ISO Hiroyasu, Director of Institute for Global Health Policy Research (iGHP), National Center for Global Health and Medicine
Program Officer (PO): ICHIJO Hidenori, Professor, Graduate School of Pharmaceutical Sciences, The University of Tokyo
Program Officer (PO): SEKITANI Tsuyoshi, Professor, SANKEN, Osaka University
In this R&D area, the goal is to develop a scientific understanding of stress responses at the individual level and the mechanisms leading to disease onset. Further goals are identifying new stress markers that provide objective indicators of biological responses to stress exposure, and developing new measuring devices or signal processing technologies that allow the capture of biological information in response to stress.
Bridging the fundamental mechanism of aging and the effective treatment of age-related disease associated with impaired functional system
Program Supervisor (PS): MOCHIZUKI Naoki, Director General, National Cerebral and Cardiovascular Center
Program Officer (PO): FUKAMIZU Akiyoshi, Director, Life Science Center for Survival Dynamics, Tsukuba Advanced Research Alliance, University of Tsukuba
Program Officer (PO): YASUTOMO Koji, Professor, Graduate School of Medical Sciences, Tokushima University
This R&D area aims to clarify the biology of the basic mechanisms involved in aging and to develop medical approaches mediated via these mechanisms. The programs will include research that uses the most up-to-date analytical technologies (genetic, imaging, omics analysis) and can be progressed from analysis in model organisms through to applied research. This R&D area will be implemented by AMED and JST together, with the two organizations liaising closely to promote the research.
Immunological memory: Understanding, regulation and medical innovation
Program Supervisor (PS): NAKAYAMA Toshinori, President, Chiba University
Program Officer (PO): TAKEDA Kiyoshi, Professor, Graduate School of Medicine, Osaka University
We welcome R&D proposals that will contribute to: (1) a new and fundamental understanding of how human immunological memory is formed, maintained, and lost; (2) clarification of novel mechanisms of cancer immunity mediated by human immunological memory; (3) an understanding of human immunological memory against infectious diseases in societies living with COVID-19 and after the COVID-19 pandemic; and (4) development of novel methods controlling allergic and autoimmune diseases, based on an understanding of human immunological memory.
Integrated understanding of multi-sensing networks and elucidation of their control mechanisms leading to the innovation of medical technologies
Program Supervisor (PS): NAGAI Ryozo, President, Jichi Medical University
Program Officer (PO): TAKEUCHI Shoji, Professor, Graduate School of Information Science and Technology, the University of Tokyo
Program Officer (PO): NISHIDA Kohji, Professor, Graduate School of Medicine, Osaka University
This R&D area aims to develop an integrated understanding of multi-sensory systems that includes sensory systems and peripheral nerve networks, and create innovative seeds for medical technologies based on an understanding of control mechanisms. This R&D area is implemented by AMED and JST together, with the two organizations liaising closely to promote the research.
Generating research infrastructure and novel technologies for anti-infective drug and vaccine discovery
Program Supervisor (PS): DOI Yohei, Professor, Departments of Microbiology and Infectious Diseases, Fujita Health University School of Medicine / Professor, Division of Infectious Diseases, University of Pittsburgh School of Medicine
Program Officer (PO): MATSUURA Yoshiharu, Director, Center for Infectious Diseases Education and Research (CiDER) and SA Professor, Laboratory of Virus Control, Research Institute for Microbial Diseases (RIMD), Osaka University
We call for research proposals in the following specific areas: (1) develop new approaches, including drug discovery modalities, that will contribute to the prevention and treatment of infectious diseases; (2) optimize existing modalities for infectious disease drug discovery; and (3) develop technology platforms that will accelerate infectious disease drug discovery and generate innovative preventive and therapeutic agents against infectious diseases.
Solicitation Period
Interview Schedule
Interview Selection Meeting
Please confirm the details as indicated below. When a hearing review is conducted, the PI will be notified by e-mail no later than one week before the interview day.
Please understand we cannot answer any questions regarding the progress status of the selection process, including the eligibility of the individual project for the hearing review.
※Interview reviews will be conducted over the Internet.
Research and Development Area | AMED-CREST | PRIME |
---|---|---|
Elucidation of mechanisms for stress responses to disease development | August 1st | August 3th August 4th |
Bridging the fundamental mechanism of aging and the effective treatment of age-related disease associated with impaired functional system | August 10th August 9th |
August 3th August 4th |
Immunological memory: Understanding, regulation and medical innovation | August 2nd | We are not offering it. |
Integrated understanding of multi-sensing networks and elucidation of their control mechanisms leading to the innovation of medical technologies |
August 9th |
August 7th |
Generating research infrastructure and novel technologies for anti-infective drug and vaccine discovery | August 1st | We are not offering it. |
Public invitation briefing
Recording of Public invitation briefing
Contents | Briefing materials |
---|---|
Elucidation of mechanisms for stress responses to disease development | Download |
Bridging the fundamental mechanism of aging and the effective treatment of age-related disease associated with impaired functional system | Download |
Immunological memory: Understanding, regulation and medical innovation | Download |
Integrated understanding of multi-sensing networks and elucidation of their control mechanisms leading to the innovation of medical technologies | Download |
Generating research infrastructure and novel technologies for anti-infective drug and vaccine discovery | Download |
How to Apply
Proposal Documents
AMED-CREST
Mandatory or Optional | Documents | Remarks |
---|---|---|
Mandatory | (Form C1)R&D Proposal | |
Mandatory | ||
Mandatory |
(Appendix C2)Human Whole Genome Sequence Analysis Protocol Form | Appendix C2 must be submitted in Excel format, if your research plan includes whole human genome analysis and/or whole exome analysis. |
PRIME
Mandatory or Optional | Documents | Remarks |
---|---|---|
Mandatory | (Form P1)R&D Proposal | |
Mandatory | (Appendix P1)Summary of Proposal (Japanese/English) |
|
Mandatory |
(Appendix P2)Human Whole Genome Sequence Analysis Protocol Form | Appendix P2 must be submitted in Excel format, if your research plan includes whole human genome analysis and/or whole exome analysis. |
Mandatory |
Additional form for duplicate application (Japanese Only) |
When making a duplicate application for the AMED PRIME and the JST PRESTO, download the "Additional form for duplicate application" at the JST PRESTO website and submit it to JST (no need to submit it to AMED). |
Reference
Links
04/11/23
Last updated 05/30/23